| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/02/2003 | US20030003445 Method of preventing cell death using antibodies to neural thread proteins |
| 01/02/2003 | US20030003444 R9Detection of preferential polypeptide in sample; obtain sample of polypeptide, incubate with bacteriophage, monitor adjustment in activity, adjustment in activity |
| 01/02/2003 | US20030003440 Immunogenic peptide for use in the detection and prevention of viral diseases |
| 01/02/2003 | US20030003108 Diagnosis and treatment of hepatic disorders |
| 01/02/2003 | US20030003106 Use of protein derived from cancer cells, cells infected by a virus or immune cells or an inactive fragment thereof, protein being initially an immunosuppressive and/or angiogenic protein for obtaining medicines to provide mucosal immunity |
| 01/02/2003 | US20030003104 Providing environment containing enterotoxigenic organism, providing antibody preparation comprising antibodies against organism, exposing environment to effective amount of antibody preparation to neutralize or purge organism |
| 01/02/2003 | US20030003102 Morpholino imaging and therapy |
| 01/02/2003 | US20030003101 Treatment and diagnosis of prostate cancer |
| 01/02/2003 | US20030003100 Gene therapy strategy, comprising an antibody-nucleic acid-cationic macromolecule complex that enhances nucleic acid delivery to mammalian cells |
| 01/02/2003 | US20030003099 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection |
| 01/02/2003 | US20030003097 Recombinant antibodies coexpressed with GnTIII |
| 01/02/2003 | US20030003096 Only specifically binds activated factor VII, and not factor VII, and does not bind to an activated factor VII which is complexed with antithrombin III |
| 01/02/2003 | US20030003071 N-methyltaurine as an active ingredient; giving hair fitness and body, and giving hair a feeling of volume |
| 01/02/2003 | EP1271153A2 Collapsin response mediator protein-1 as tumor metastasis marker |
| 01/02/2003 | EP1270723A1 Anticomplement polyptide from salivary glands of the tick Ixodes ricinus |
| 01/02/2003 | EP1270596A1 Antibody/carrier complex, process for producing the same, method of controlling antigen-antibody reaction by using the same and immunoassay method |
| 01/02/2003 | EP1270595A1 Gene recombinant antibody and its fragment |
| 01/02/2003 | EP1270594A1 Antibodies to peptide from a soluble fragment of acetylcholinesterase |
| 01/02/2003 | EP1270593A2 HSCA-3 antigen and monoclonal antibody which recognizes the antigen |
| 01/02/2003 | EP1270592A1 Monoclonal antibody, mAb 1E8, which is specific for the first 2 amino-terminal amino acids of beta-amyloid peptides and its use in the detection of beta-amyloid peptides or sAPPs |
| 01/02/2003 | EP1270590A1 Human CD24-like protein and nucleic acids encoding it |
| 01/02/2003 | EP1270588A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 01/02/2003 | EP1269199A2 Methods involving induced dimerisation by cellular components |
| 01/02/2003 | EP1269196A1 Method of screening for inhibitors of osteopontin |
| 01/02/2003 | EP1268836A2 Novel sperm-dna complexes for genetically modifying non-human animals |
| 01/02/2003 | EP1268832A1 Production of antibodies in transgenic plastids |
| 01/02/2003 | EP1268820A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/02/2003 | EP1268817A1 Human pyruvate dehydrogenese phosphatase |
| 01/02/2003 | EP1268816A2 Calcium-binding regulatory subunit |
| 01/02/2003 | EP1268813A2 Thermophilic polymerase iii holoenzyme |
| 01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 01/02/2003 | EP1268801A2 A method for in vitro molecular evolution of antibody function |
| 01/02/2003 | EP1268800A2 Mucin-1 specific binding members and methods of use thereof |
| 01/02/2003 | EP1268799A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 01/02/2003 | EP1268798A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 01/02/2003 | EP1268797A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/02/2003 | EP1268796A1 Identification of human gaba transporter |
| 01/02/2003 | EP1268794A2 Compositions and methods related to canine igg and canine il-13 receptors |
| 01/02/2003 | EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/02/2003 | EP1268792A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 01/02/2003 | EP1268790A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/02/2003 | EP1268787A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 01/02/2003 | EP1268786A2 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis |
| 01/02/2003 | EP1268785A2 Gtp-binding protein gamma-12 subunit |
| 01/02/2003 | EP1268784A2 Genes involved in intestinal inflammatory diseases and use thereof |
| 01/02/2003 | EP1268783A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 01/02/2003 | EP1268782A2 Apolipoprotein-a-i regulation of t-cell signalling |
| 01/02/2003 | EP1268781A2 G12l, a gene associated with the thermal response |
| 01/02/2003 | EP1268778A1 Materials and methods relating to a novel splice variant of a na + dependent glutamate transporter |
| 01/02/2003 | EP1268774A2 Identification of essential genes in prokaryotes |
| 01/02/2003 | EP1268773A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 01/02/2003 | EP1268771A1 Human gata-5 transcription factor |
| 01/02/2003 | EP1268766A2 Improvements to ribosome display |
| 01/02/2003 | EP1268764A2 Method for obtaining nucleic acids from an environment sample |
| 01/02/2003 | EP1268753A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268554A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 01/02/2003 | EP1268553A1 Use of cd25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract |
| 01/02/2003 | EP1268552A2 Method for identifying substances which mimic mammal epitopes |
| 01/02/2003 | EP1268551A2 A METHOD OF PRODUCING IgG |
| 01/02/2003 | EP1268550A2 Human fap-alpha-specific antibodies |
| 01/02/2003 | EP1268543A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268542A2 Therapeutic anti-melanoma compounds |
| 01/02/2003 | EP1268541A1 7 human ovarian and ovarian cancer associated proteins |
| 01/02/2003 | EP1268540A2 Proteins amf-1 to amf-10 and nucleic acids encoding same |
| 01/02/2003 | EP1268528A2 Human genes and expression products |
| 01/02/2003 | EP1268526A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/02/2003 | EP1268516A1 Methods for detection and treatment of neural cancers |
| 01/02/2003 | EP1268510A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 01/02/2003 | EP1267940A1 Compounds for targeting |
| 01/02/2003 | EP1267934A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 01/02/2003 | EP1267930A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 01/02/2003 | EP1267928A2 Methods for immunostimulation using bispecific binding agents for the fc receptor of immunoglobulin a and for cancer cells or infectious antigen |
| 01/02/2003 | EP1267927A1 Methods of therapy for non-hodgkin's lymphoma using a combination of an antibody to cd20 and interleukin-2 |
| 01/02/2003 | EP1267926A2 Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2 |
| 01/02/2003 | EP1267925A1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP1267905A2 Composition for the treatment of heart failure |
| 01/02/2003 | EP1267903A1 Methods for treating glaucoma |
| 01/02/2003 | EP1105428A4 Novel cleaved fragments of fibrinogen |
| 01/02/2003 | EP1078040A4 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 01/02/2003 | EP0999853B1 Stabilized antibody formulation |
| 01/02/2003 | EP0885244B1 Peptide immunogens for vaccination against and treatment of allergy |
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/02/2003 | EP0725081B1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
| 01/02/2003 | CA2392344A1 Method for removal of pathogens from a localized environment |
| 01/01/2003 | CN1388136A Double-specificity antibody resisting human ovary cancer and human CD3 |
| 01/01/2003 | CN1388135A Monoclonal antibody capable of priming cancer cell death |
| 01/01/2003 | CN1388132A Cell death inducing protein and its coding sequence and use |
| 01/01/2003 | CN1097467C Vaccine compositions |
| 12/31/2002 | US6500941 Secreted by human breast cancer mda-mb-175 cells, leads to the formation of a constitutive active receptor complex and stimulates these cells in an autocrine manner |
| 12/31/2002 | US6500937 Plasmid or vector; sequence encodes mammastatin; useful in the diagnosis and treatment of breast cancer |
| 12/31/2002 | US6500933 Methods of preparing carbohydrate crosslinked glycoprotein crystals |
| 12/31/2002 | US6500932 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same |
| 12/31/2002 | US6500931 Portion of a complementarity determining region (cdr) derived from a non-human antibody with remaining portions human in origin; use in immunotherapy or as immunotoxins |
| 12/31/2002 | US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors |
| 12/31/2002 | US6500922 Native polypeptide factors that are capable of association with the intracellular domain of tnf-r2 and participate in the intracellular post-receptor signaling of tnf biological activities |
| 12/31/2002 | US6500919 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |